Valsartil 40 mg is an oral antihypertensive medication belonging to the class of Angiotensin II Receptor Blockers (ARBs). It is primarily prescribed for the management of hypertension, reduction of hospitalizations in congestive heart failure (CHF), and to reduce mortality in patients who develop CHF after a myocardial infarction (heart attack).

The active ingredient, Valsartan, specifically blocks the AT1 subtype of angiotensin II receptors, preventing the narrowing of blood vessels and thereby reducing blood pressure. Valsartil 40 mg lowers blood pressure without significantly affecting the heart rate, making it suitable for patients with cardiovascular risk factors.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Angiotensin II Receptor Blocker (ARB)

Indications

Valsartil 40 mg is indicated for:

1. Hypertension: To lower high blood pressure and prevent complications such as stroke, heart attack, and kidney damage.

2. Congestive Heart Failure: To reduce hospitalizations in patients with CHF by decreasing strain on the heart.

3. Post-Myocardial Infarction: To reduce the risk of death and improve survival in patients who develop CHF after a heart attack.

Pharmacology

Valsartil 40 mg is a selective angiotensin II receptor antagonist:

• Mechanism of Action: Blocks angiotensin II from binding to AT1 receptors, preventing vasoconstriction.

• Effect: Dilates blood vessels, reduces blood pressure, and decreases cardiac workload.

• Selectivity: Over 20,000 times higher affinity for AT1 than AT2 receptors, minimizing off-target effects.

• Metabolism: Minimally metabolized in the liver; primarily excreted in bile and feces.

Dosage & Administration

Hypertension:

• Typical dose: 80–160 mg once daily

• Maximum dose: 320 mg daily

• Maximum effect is usually achieved within 4 weeks

Heart Failure:

• Initial dose: 40 mg twice daily

• Can be increased up to 80–160 mg twice daily as tolerated

Post-Myocardial Infarction:

• Initial dose: 20 mg twice daily

• Titrated up to a target of 160 mg daily if tolerated

Administration Notes:

• Should be taken on an empty stomach (food reduces absorption by ~40%)

• No dose adjustment needed for elderly patients with mild to moderate renal or hepatic impairment

Drug Interactions

• No clinically significant interactions with commonly used drugs such as digoxin, warfarin, furosemide, cimetidine, hydrochlorothiazide, amlodipine, atenolol, or glibenclamide

• Caution: Concomitant use of potassium-sparing diuretics, potassium supplements, or salt substitutes may increase serum potassium levels

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Contraindications

• Known hypersensitivity to Valsartil or any component of the formulation

• Severe hepatic impairment

• Pregnancy (2nd and 3rd trimester)

Side Effects

Common adverse effects include:

• Cardiovascular: Hypotension, dizziness, headache

• Gastrointestinal: Nausea, abdominal pain, diarrhea

• Other: Fatigue, cough, back pain, muscle cramps, rash, hyperkalemia

Rare but serious effects: Impaired renal function or allergic reactions

Precautions & Warnings

• Pregnancy: Avoid during 2nd and 3rd trimester; discontinue immediately if pregnancy is detected

• Lactation: Unknown if excreted in breast milk; weigh risk vs. benefit

• Hepatic Impairment: Dose adjustment required; contraindicated in severe impairment

• Renal Impairment: Monitor closely; dose reduction may be necessary

• Heart Failure & Post-MI: Start with caution; monitor blood pressure and renal function

Overdose

• Likely manifestations: hypotension, tachycardia, or bradycardia

• Management: Place patient in supine position, administer IV normal saline if necessary, and monitor vital signs

Storage

• Store between 15–30°C

• Protect from moisture and heat

• Keep out of reach of children

Mode of Action

Valsartil 40 mg selectively blocks angiotensin II from binding to AT1 receptors, preventing vasoconstriction, lowering blood pressure, and reducing cardiac workload. Unlike other antihypertensives, it does not significantly affect heart rate or other hormone pathways involved in cardiovascular regulation.

Special Populations

• Pediatric Use: Safety and efficacy not established

• Geriatric Use: No overall differences, but some elderly patients may be more sensitive

• Hepatic Impairment: Mild to moderate: Max 80 mg once daily; severe: contraindicated.